• STAT Plus: FDA to experiment with releasing clinical trial summary reports

    7 monthes ago - By STAT

    In a bid to become more transparent, the Food and Drug Administration is launching a program to determine the benefits of disclosing certain summaries of clinical trial data, a notion that has evoked long-standing debate over patient privacy, trade secrets, and improving medical research.
    The program will release so-called clinical study reports, which contain summary information and analysis, from up to nine different applications filed by companies that seek to market new prescription drugs. The agency plans to rely on drug makers to volunteer to participate. Continue to STAT Plus to...
    Read more ...